Avoiding alcohol lowers the risk of several cancers, prevents and partly reverses liver disease, improves sleep, lowers blood pressure, and reduces irregular heartbeats. Benefits are largest for heavier drinkers, women, and those with certain gene variants. The old belief that a daily drink protects the heart is now contested. Stopping suddenly when dependent needs medical support. (Full Review)

Protocol

Approach

Full abstinence

or harm reduction toward the lowest feasible intake

Entry Points

Dry January

or structured brief interventions in primary care

For Dependence

Naltrexone or acamprosate

first-line, combined with counseling; disulfiram as an aversive option

Time to effect

Cancer & Cardiovascular Risk

Months to years

declines gradually over sustained avoidance

Liver Fat

Weeks

hepatic fat frequently regresses within 4–6 weeks

Sleep

Days

REM suppression resolves within several alcohol-free nights

Benefits

High: Reduced risk of alcohol-related cancers; prevention and reversal of liver disease; lower mortality relative to higher-volume drinking

Medium: Improved sleep quality; reduced blood pressure; reduced atrial fibrillation burden; reduced cardiovascular risk (conflicted)

Low: Improved mood and mental health; weight and metabolic benefits

Speculative: Slower brain aging and cognitive preservation; improved gut and immune function

Contraindications

Abrupt cessation in physically dependent individuals (e.g., daily heavy intake with prior withdrawal symptoms)

Key Interactions

Sedatives and benzodiazepines (diazepam, lorazepam), opioid painkillers

Metronidazole, warfarin, certain diabetes medicines

Acetaminophen (paracetamol), NSAIDs (ibuprofen, aspirin)

Sedative supplements (valerian, melatonin, kava), high-dose fish oil

Other central nervous system depressants (cannabis, antihistamines, sleep aids)

Risk & Side Effects

High: Alcohol withdrawal syndrome in physically dependent individuals

Medium: Social and psychological adjustment and relapse; early sleep disruption and anxiety

Low: Forgone modest cardiovascular benefit in light drinkers (conflicted)

Speculative: Compensatory behaviors

Monitoring

Marker	Target	Why
GGT	< 20–25 U/L	Sensitive early marker of alcohol-related liver stress
AST and ALT	< 25 U/L each	Detect ongoing liver-cell injury
CDT	< 1.7%	Confirms sustained reduction in heavy intake
MCV	80–90 fL	Chronic alcohol enlarges red cells
PEth	< 20 ng/mL	Objectively confirms abstinence or reduction
Blood pressure	< 120/80 mmHg	Alcohol raises blood pressure dose-dependently
Triglycerides	< 90 mg/dL	Alcohol commonly raises triglycerides

Cadence: First recheck at 4–8 weeks, again at 3–6 months, then every 6–12 months once markers have stabilized

Qualitative Assessment

Sleep quality and how rested mornings feel
Daytime energy and physical stamina
Mood stability and anxiety levels
Cravings for alcohol and their frequency
Cognitive clarity and concentration
Skin appearance and hydration

Avoiding Alcohol for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment